National Center for Science (NCN) grant for novel gene expression system
Prof. dr hab. Piotr Mariusz Skowron (University of Gdansk) has received National Center for Science (NCN) grant in the amount of 2,197,200..
top of page
Unia Europejska
Recent news
Archived news
May 7
Development of prototype poly-RGD pro-regenerative drug
The DNA FACE™ concept has been successfully used to develop prototype pro-regenerative drug. The EP 3.549.947.B1 patent is a result of long.
Mar 14
New publication in Microbial Cell Factories
One of the leading current trends in technology is the miniaturization of devices to the microscale and nanoscale. The highly advanced...
Mar 8
Publication in the International Journal of Molecular Sciences: thermophilic bacteriophages.
Bacteriophages associated with thermophiles are gaining increased attention due to their pivotal roles...
Jan 5
Publication in the International Journal of Molecular Sciences: targeting capsular bacteria
One of current trends in medical treatment is developing targeted therapeutic interventions against capsular bacteria. The publication...
Aug 29, 2023
Zawiadomienie o rozstrzygnięciu postępowania
Zamawiający BioVentures Institute Sp. z o.o informuje, że w wyniku przeprowadzonego postępowania na usługę: Opracowanie technologii...
Jul 11, 2023
ZAPYTANIE OFERTOWE
BioVentures Institute Sp. z o.o, jako podmiot realizujący projekt współfinansowany z Europejskiego Funduszu Rozwoju Regionalnego na...
Jun 3, 2023
New publication in Critical Reviews in Microbiology
This publication is a result of long-term scientific cooperation and partnership between BioVentures Institute, University of Gdańsk,...
Feb 10, 2023
Grant dla BioVentures Institute Sp. z o.o.
BioVentures Institute Sp. z o.o. otrzymała dofinansowanie w ramach programu "Granty B+R dla przedsiębiorstw"
Aug 2, 2022
New publication in Microorganisms
This publication is a result of long-term scientific cooperation and partnership between BioVentures Institute, University of Gdańsk,...
May 15, 2022
Development of prototype PDGF pro-regenerative drug
The DNA FACE™ concept has been successfully used to develop prototype pro-regenerative drug. The PL 240667 patent is a result...
Jan 28, 2022
New Publication in Microbial Cell Factories
This publication is a result of long-term scientific cooperation and partnership between BioVentures Institute, University of Gdańsk,...
Oct 1, 2021
Grant from The National Centre for Research and Development
The National Centre for Research and Development grant TECHMATSTRATEG2/410747/11/NCBR/2019 (2019-2022) to the Consortium led by...
Jul 1, 2021
Bacteriophages of Thermophilic ‘Bacillus Group’Bacteria—A Review
The publication reviewing potential and used by BioVentures Institute thermophilic bacteriophages and Virus-Like-Particles (VLPs)...
Jun 20, 2021
Positive initial animal trials of the recombinant anti-SARS-CoV-2 vaccine
The vaccine has been purified, analysed using a number of techniques, including electrophoresis, LC-MS, Western blotting and was...
Apr 1, 2021
Development of a novel type of recombinant anti-SARS-CoV-2 vaccine
The DNA-FACE™ concept of construction of ‘artificial’, concatemeric protein with a vaccine functionality has been used to construct an...
Mar 9, 2021
Patent in Israel granted for DNA-FACE™
Our break-through recombinant DNA biotechnology for the construction of a new generation vaccines, biologics, biosimilars, industrial and...
Dec 31, 2020
Patent in US granted for DNA-FACE™
Our break-through recombinant DNA biotechnology for the construction of a new generation vaccines, biologics, biosimilars, industrial and...
Nov 2, 2020
Funds from The National Centre for Research and Development
The National Centre for Research and Development grant TECHMATSTRATEG-III/0042/2019 (2020-2023) received by the Institute...
Aug 27, 2020
Patent for EU
Our break-through recombinant DNA biotechnology for the construction of a new generation vaccines, biologics, biosimilars, industrial and...
bottom of page